All Square Wealth Management LLC Gilead Sciences, Inc. Transaction History

All Square Wealth Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 11, 2021	SELL	$60.0 - $68.46 $3,000 - $3,422	-50 Closed	0 $0
Q4 2020 Feb 09, 2021	SELL	$56.65 - $64.55 $4,248 - $4,841	-75 Reduced 60.0%	50 $3,000
Q2 2020 Aug 11, 2020	BUY	$72.34 - $84.0 $3,617 - $4,200	50 Added 66.67%	125 $10,000
Q1 2020 May 12, 2020	SELL	$62.63 - $80.22 $6,263 - $8,022	-100 Reduced 57.14%	75 $6,000
Q2 2019 Aug 13, 2019	SELL	$61.87 - $69.38 $30,935 - $34,690	-500 Reduced 74.07%	175 $12,000
Q2 2018 Aug 14, 2018	SELL	$64.88 - $75.68 $34,062 - $39,732	-525 Reduced 43.75%	675 $48,000
Q3 2017 Nov 06, 2017	BUY	$72.11 - $85.47 $86,532 - $102,564	1,200	1,200 $97,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of All Square Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on All Square Wealth Management LLC with notifications on news.